A ‘Real-World’ Analysis of Persistence on and Adherence to Glipizide GITS, Glipizide IR and Glibenclamide in Managed Care among Patients with Type 2 Diabetes Mellitus

Author： Harley C.R.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.9, 2002-01, pp. : 575-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type-2 diabetes

By Jönsson Anders   Chan Juliana C.N.   Rydberg Tony   Vaaler Stein   Hallengren Bengt   Cockram Clive S.   Critchley Julian A.J.H.   Melander Arne  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 711-714

Springer Publishing Company

Access to resources Recommend Favorite

Patient compliance in type 2 DM best with glipizide GITS

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 379, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Glipizide: A Review of the Pharmacoeconomic Implications of the Extended-Release Formulation in Type 2 Diabetes Mellitus

By Foster R.H.   Plosker G.L.  

PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. : 289-306

Adis International

Access to resources Recommend Favorite

The Pharmaceutical care of patients with type 2 diabetes mellitus

By Borges Anna  

Pharmacy World and Science, Vol. 32, Iss. 6, 2010-12 ,pp. : 730-736

Springer Publishing Company

Access to resources Recommend Favorite

Glibenclamide/glipizide: Hypoglycaemia: 14 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1327, 2010-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite